A Multi-Center, Randomized, Double-Blind, Placebo Controlled Phase 3 Safety and Effectiveness Trial of a Vaginal Matrix Ring With Dapivirine for the Prevention of HIV-1 Infection in Women
Phase of Trial: Phase I/II
Latest Information Update: 24 Dec 2016
At a glance
- Drugs Dapivirine (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 27 Jun 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 27 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Dec 2010 Additional lead trial investigator identified as reported by ClinicalTrials.gov.